We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

PAMT:NASDAQPAMT CORP Analysis

Data as of 2026-05-25 - not real-time

$11.98

Latest Price

8/10Risk

Risk Level: High

Executive Summary

PAMT is trading above its 20‑day and 50‑day moving averages and the MACD histogram is positive, suggesting short‑term momentum, while the RSI sits in the upper‑mid range, indicating continued buying pressure. The stock benefits from an "Extreme Greed" market sentiment and a beta well above one, pointing to heightened sensitivity to market swings and a 30‑day volatility above 70%, which amplifies both upside and downside potential. Technical signals are bullish, but the price remains close to a calculated support near $9.08, leaving limited downside cushion.
Fundamentally, the company posted a negligible Q1 loss, continues to generate negative operating and net margins, and carries a debt‑to‑equity ratio above 150%, dwarfing its modest cash balance. The absence of any dividend and a negative free cash flow profile underscore cash‑flow strain, while a price‑to‑book around 1.2 and a price‑to‑sales below 0.5 hint at a valuation that is low relative to assets and revenue but not supported by earnings. Overall, the blend of strong short‑term technicals and weak fundamentals creates a precarious investment case.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish technical alignment (price above short‑term SMAs, MACD bullish)
  • High short‑term volatility and beta increasing market sensitivity
  • Continued cash‑flow deficit limiting immediate upside

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Persistent negative operating margins and earnings
  • Elevated leverage with debt‑to‑equity >150%
  • Lack of dividend and limited free cash flow generation

Long Term

> 3 years
Cautious
Model confidence: 8/10

Key Factors

  • Structural debt burden may constrain strategic investments
  • Industry cyclicality and potential regulatory headwinds for trucking
  • Absence of a clear turnaround catalyst despite low valuation multiples

Key Metrics & Analysis

Financial Health

Revenue Growth-8.70%
Profit Margin-7.61%
ROE-18.53%
ROA-7.42%
Debt/Equity155.70
P/B Ratio1.2
Op. Cash Flow$9.7M
Free Cash Flow$-7130500
Industry P/E29.7

Technical Analysis

TrendNeutral
RSI65.0
Support$9.08
Resistance$12.36
MA 20$10.47
MA 50$9.48
MA 200$10.83
MACDBullish
VolumeStable
Fear & Greed Index91.8

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta1.66
Volatility76.42%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.